The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-[(5-Methylsulfonyl-1H-indol-2-yl)methyl]-1-(1-naphthyl)ethanamine ID: ALA3752605
PubChem CID: 57385842
Max Phase: Preclinical
Molecular Formula: C22H22N2O2S
Molecular Weight: 378.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](NCc1cc2cc(S(C)(=O)=O)ccc2[nH]1)c1cccc2ccccc12
Standard InChI: InChI=1S/C22H22N2O2S/c1-15(20-9-5-7-16-6-3-4-8-21(16)20)23-14-18-12-17-13-19(27(2,25)26)10-11-22(17)24-18/h3-13,15,23-24H,14H2,1-2H3/t15-/m1/s1
Standard InChI Key: FHWXNNHLLAGJTK-OAHLLOKOSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-1.2896 2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3263 3.6026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0131 3.7434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0200 5.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4761 7.4707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3227 5.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6465 5.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6674 6.4577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1709 6.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9455 7.7257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2184 9.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6990 9.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9403 7.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4462 7.7121 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0551 8.7462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0376 6.6680 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6462 7.7020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 1
1 3 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
4 13 2 0
8 13 1 0
1 4 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
15 23 1 0
18 23 2 0
14 16 1 0
3 14 1 0
20 24 1 0
24 25 1 0
24 26 2 0
27 24 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.50Molecular Weight (Monoisotopic): 378.1402AlogP: 4.58#Rotatable Bonds: 5Polar Surface Area: 61.96Molecular Species: BASEHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.62CX LogP: 3.52CX LogD: 2.28Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -1.29
References 1. Kiefer L, Beaumard F, Gorojankina T, Faure H, Ruat M, Dodd RH.. (2016) Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists., 24 (4): [PMID:26752095 ] [10.1016/j.bmc.2015.12.019 ]